An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

Detailed price information for Avenue Therapeutics Inc (ATXI) from The Globe and Mail including charting and trades.

STOCKHOLM, June 23, 2025 /PRNewswire/ -- Atrogi AB, a clinical-stage biotechnology company pioneering muscle-targeted therapies, today announces the publication of a landmark study in the prestigious ...

Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC). Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic ...

The popularity of GLP-1-based drugs is testament to the importance of a drug that increases fat burning and lowers blood sugar. Now, a drug—taken in the form of a tablet—offers the outcome of ...